4//SEC Filing
Andreev-Kaspin Tanya 4
Accession 0001628280-21-024472
CIK 0001835378other
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 8:12 PM ET
Size
12.8 KB
Accession
0001628280-21-024472
Insider Transaction Report
Form 4
Andreev-Kaspin Tanya
Chief Financial Officer
Transactions
- Award
Stock Options
2021-11-30+153,784→ 153,784 totalExercise: $2.81Exp: 2031-04-29→ Common Stock (153,784 underlying) - Award
Stock Options
2021-11-30+200,588→ 200,588 totalExercise: $0.61Exp: 2030-11-15→ Common Stock (200,588 underlying) - Award
Stock Options
2021-11-30+50,369→ 50,369 totalExercise: $0.46Exp: 2026-07-13→ Common Stock (50,369 underlying) - Award
Common Stock
2021-11-30+267,450→ 267,450 total
Footnotes (3)
- [F1]On November 30, 2021, pursuant to that certain Agreement and Plan of Merger, dated as of June 24, 2021, by and among ION Acuqisition Corp 2 Ltd. ("ION"), Inspire Merger Sub 1, Inc.. ("Merger Sub"), Inspire Merger Sub 2, LLC ("Merger Sub 2") and Innovid, Inc. ("Innovid"), (i) Merger Sub merged with and into Innovid (the "First Merger"), with Innovid surviving as a wholly owned subsidiary of ION (the "Surviving Corporation"), and (ii) immediately following the First Merger and as part of the same overall transaction as the First Merger, the Surviving Corporation merged with and into Merger Sub 2 (the "Second Merger"), with Merger Sub 2 being the surviving entity in the Second Merger and continuing as a wholly-owned subsidiary of ION. Upon the effective time of the First Merger (the "Effective Time"), each issued and outstanding share of common stock of Innovid was automatically cancelled and converted into approximately 1.337 (the "Exchange Ratio") shares of common stock of ION.
- [F2]25% of the shares subject to the option vested or will vest 12 months after the grant date, and l/12th of the shares subject to the options vested or will vest quarterly thereafter, subject to continued service through each vesting date. Upon a termination by Innovid without cause or by the named executive for good reason, in each case, within 12 months following a qualifying corporate transaction, all unvested shares subject to the option will accelerate and vest.
- [F3]At the Effective Time, each outstanding option to purchase shares of Innovid common stock (each, an "Innovid Option") was automatically cancelled and converted into an option to purchase a number of shares of common stock of ION equal to (i) the number of shares of Innovid common stock subject to the applicable Innovid Option multiplied by (ii) the Exchange Ratio, rounded down to the nearest whole share.
Documents
Issuer
Innovid Corp.
CIK 0001835378
Entity typeother
Related Parties
1- filerCIK 0001896113
Filing Metadata
- Form type
- 4
- Filed
- Dec 1, 7:00 PM ET
- Accepted
- Dec 2, 8:12 PM ET
- Size
- 12.8 KB